HCV-NS3 polyclonal, anti-human, virus

Protein Family: Enzymes, Peptidases

Pathway and Disease: Cancers, Cell Growth and Death, Immune System, Infectious Diseases, Lipid Metabolism, Signaling Molecules and Interaction, Transcription

Description:
Hepatitis C virus (HCV) helicase (non-structural protein 3, NS3) is involved in HCV genome replication and is considered a target for inhibition of HCV. Protease NS2-3 is a cysteine protease responsible for the autocatalytic cleavage of NS2-NS3. The protease is self-inactivated following maturation. NS3 has three enzymatic activities: serine protease, NTPase and RNA helicase. NS3 serine protease in association with NS4A is responsible for the cleavages of NS3-NS4A, NS4A-NS4B, NS4B-NS5A and NS5A-NS5B. NS3/NS4A complex also prevents phosphorylation of human IRF3, thus preventing the establishment of dsRNA induced antiviral state. NS3 RNA helicase binds to RNA and unwinds dsRNA in the 3' to 5' direction, and likely RNA stable secondary structure in the template strand. NS3 cleaves and inhibits the host antiviral protein MAVS.

Alternate Names: Genome polyprotein hepatitis virus C, Helicase NS3, Non-structural protein 3, Hepacivirin, NS3P, p70

Application Notes: E: 1:500-1:1,000; WB: 1:200-1:500; IHC: 1:200-1:500

Accession No.: P26663

Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of HCV-NS3.

Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4, 25% glycerol, 1 mg/ml BSA with 0.09% sodium azide. Antibody was purified by Protein-A affinity chromatography.

Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.